Our funding

MPE has received funding from the following sources in 2022 and 2023:

Industry supporters

  • AbbVie
  • Amgen
  • Alexion
  • BeiGene
  • Binding Site
  • Bristol Myers Squibb
  • GlaxoSmithKline
  • Janssen
  • Novartis
  • Oncopeptides
  • Pfizer
  • Regeneron
  • Roche
  • Sanofi
  • Menarini Stemline
  • Takeda
  • Sebia
  • Prothena
  • SkylineDx
  • Sandoz

Public supporters

Horizon Europe
  • Horizon 2020 CARAMBA

European Union logo for public funded projects

 

 

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 754658.

  • Horizon Europe ASCERTAIN

European Union logo for public funded projects

 

 

This project has received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement No 101094938.

Innovative Medicine Initiative (IMI)
  • IMI HARMONY
  • SISAQOL IMI

You can freely download the funding sources reports by clicking on the links below:

Group 1501